methylselenic acid has been researched along with 9,10-dimethyl-1,2-benzanthracene in 1 studies
| Studies (methylselenic acid) | Trials (methylselenic acid) | Recent Studies (post-2010) (methylselenic acid) | Studies (9,10-dimethyl-1,2-benzanthracene) | Trials (9,10-dimethyl-1,2-benzanthracene) | Recent Studies (post-2010) (9,10-dimethyl-1,2-benzanthracene) |
|---|---|---|---|---|---|
| 144 | 1 | 68 | 6,010 | 10 | 772 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ganther, HE; Ip, C; Thompson, HJ; Zhu, Z | 1 |
1 other study(ies) available for methylselenic acid and 9,10-dimethyl-1,2-benzanthracene
| Article | Year |
|---|---|
In vitro and in vivo studies of methylseleninic acid: evidence that a monomethylated selenium metabolite is critical for cancer chemoprevention.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Apoptosis; Carcinogens; Comet Assay; Female; Glutathione Peroxidase; Liver; Lyases; Mammary Neoplasms, Experimental; Methylnitrosourea; Mice; Neoplasms, Experimental; Organoselenium Compounds; Rats; Rats, Sprague-Dawley; Selenium; Thioredoxin-Disulfide Reductase; Tissue Distribution; Tumor Cells, Cultured | 2000 |